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ello et al., 1990; Christinck et al., 1991; Brower et al.,and David M. Kranz*
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interaction. Recent findings suggest that a single ligand†Department of Biology and Center for Cancer Research
complex may trigger multiple TCRs (Valitutti et al., 1995),Massachusetts Institute of Technology
and thusthis stochiometry can not be assumed. Further-Cambridge, Massachusetts 02139
more, binding of the TCR to its ligand also appears to
facilitate ligand binding by other T cellsurface molecules
such as CD8 and LFA-1 (Mescher et al., 1991). The rela-
Summary tive contributions of each of these interactions to the
activation of a T cell and the intrinsic affinities of the
The number of T cell receptors on CTL clone 2C that interactions between various receptors and their ligands
are required for recognition of various peptide–MHC are only beginning to be understood.
or superantigen–MHC ligands were measured as a To explore various aspects of the interaction between
function of both the ligand density on target cells and the TCR and its ligand, we examined the recognition
the binding affinity of the TCR. Quantitative inverse and lysis of target cells by the alloreactive CTL clone
correlations were determined between the number of 2C (Kranz et al., 1984a). Several naturally occurring pep-
TCRs required for recognition and the number of li- tides are recognized by CTL 2C, including peptides
gands on target cells, and the number of TCR required p2Ca (LSPFPFDL; Udaka et al., 1992) and QL9
and the Ka of the TCR for the ligand. We propose and (QLSPFPFDL; Sykulev et al., 1994b) when complexed
test predictive uses of these relationships to deter- to the MHC product Ld. This system offers unique oppor-
mine the number of endogenous peptide–MHC com- tunities for study because the affinities have been deter-
plexes on a target cell (when TCR affinity is known) mined for the binding of some of these peptides to Ld
or to determine the affinity of the TCR (when the num- and of the peptide–MHC complexes to the TCR (Corr
ber of ligands is known). et al., 1994; Sykulev et al., 1994a, 1994b; Al-Ramadi et
al., 1995); the QL9–Ld complex has the highest known
affinity of a ligand for the TCR (Sykulev et al., 1994b);
Introduction several variants of the peptides p2Ca and QL9 have
been characterized with respect to binding to both the
The recognition of target cell antigens by CD81 T cells Ld and the TCR, and have been shown to have a wide
depends upon multiple reversible interactions. The mini- range of MHC binding affinities and abilities to be recog-
mal interactions involve the binding of peptides to class nized by the CTL 2C (Al-Ramadi et al., 1995; Sykulev et
I MHC proteins and the binding of antigen-specific re- al., 1994a; C. J. Schlueter et al., submitted); and, finally,
ceptors on T cell receptors (TCRs) to peptide–major a clonotypic monoclonal antibody, 1B2, is available to
histocompatibilty complexes (MHCs) on target cells. inhibit recognition by CTL 2C (Kranz et al., 1984b).
Several laboratories have reported binding affinities for In addition, because 2C contains the Vb8 region, CTL
the interactions of the TCR with the peptide–MHC com- 2C recognizes the staphylococcal enterotoxins B, C1,
plex (Schneck et al., 1989; Matsui et al., 1991; Weber et and C3 (SEB, SEC1, and SEC3, respectively) bound to
al., 1992; Sykulev et al., 1994a; Corr et al., 1994; class II MHC products (Soo Hoo and Kranz, 1993). The
Schlueter et al., 1996), and these interactions are of low binding affinities of these superantigens for the TCR
to moderate affinity. The interaction of CD8 molecules have been reported (Malchiodi et al., 1995) and the affini-
on T cells with the peptide–MHC–TCR complex in- ties of SEB and SEC1 binding to class II MHC are known
creases the avidity of the T cell–target cell interaction by (Scholl et al., 1989; Mollick et al., 1991; Seth et al., 1994).
stabilizing these complexes, or transducing activation In this study, we examined thenumber of TCRs on CTL
signals in the responding T cells, or both (O’Rourke and 2C required to recognize target cells that bear different
Mescher, 1993). densities of various peptide–MHC ligands and various
CD81 T cells can also recognize, via the TCR,superan- SE–MHC ligands. The density of peptide–MHC or SE–
tigens bound to class II MHC products (Marrack and MHC complexes was varied by incubating target cells
Kappler, 1990). This recognition differs in topology from with various concentrations of synthetic peptide or SE
conventional peptide–MHC recognition by T cells in that antigen. The effective number of TCR molecules was
binding occurs primarily through the b chain of the TCR controlled by incubating the 2C cells with varying
(Choi et al., 1990; White et al., 1989). Although CD8 may amounts of Fab fragments from 1B2. The number of
be required for T cell signaling in the case of superanti- TCR required for recognition of each ligand could be
gen–MHC-mediated activation, it does not appear to be calculated because 1B2 completely inhibits the recogni-
essential for recognition (Soo Hoo and Kranz, 1993). tion of both peptide–MHC and SE–MHC ligands, and
There are approximately 105 TCRs expressed on the because the affinity of 1B2 for the 2C TCR is known
surface of a cytotoxic T lymphocyte (CTL), and it has (Sykulev et al., 1994a). Thus, it was possible toquantitate
the number of ligands per target cell and the number ofbeen suggested that engagement of anywhere from
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available TCR per CTL using known equilibrium binding 2C expresses Vb8.2 and hence it should also recog-
nize theSE antigens SEB, SEC1, and SEC3. The affinitiesconstants.
Our principal findings substantiate the role of ligand of these superantigens for soluble Vb8.2 has recently
been reported (Malchiodi et al., 1995) (Table 1). To con-density on target cells (peptide–MHC or SE–MHC com-
plexes) and they show that there is a direct and measur- firm that 2C recognizes these SE antigens, SEB, SEC1,
and SEC3 were incubated with the class II–positive cellable relationship between the TCR binding affinity and
the total number of cell surface TCR molecules required line Daudi at various concentrations and assayed in a
cytotoxicity assay with CTL 2C (Figure 1). All three SEsto trigger CTL activity. At the lowest ligand densities
that trigger T cell activity, nearly all of the available were recognized by 2C, with activity curves that were
proportional to the measured affinities for the TCR (i.e.,100,000 TCRs/cell were required, regardless of the affin-
ity of the ligand for the TCR. At the highest ligand densi- SD50 of SEB > SEC1 > SEC3, where SD50 is the sensitiza-
tion dose required for 50% of maximal lysis).ties, the number of TCRs required for activity inversely
correlated with the affinity of the ligand for the TCR.
The high affinity ligands required z1,000 total available Inhibition of SE Recognition by 1B2 Fab Fragments
TCRs/cell for activity, and the low affinity ligands re- It has been shown previously that the clonotypic anti-
quired > 50,000 total available TCRs/cell for activity. The body 1B2 can inhibit both 2C-mediated lysis of p2Ca–Ld
values for the total number of TCRs required do not target cells and the binding of soluble p2Ca–Ld to 2C
directly reflect the number of TCRs engaged with ligand. (Kranz et al., 1984b; Sykulev et al., 1994a). This finding
However, the data suggest that more than a single TCR is not surprising, as 1B2 is thought to recognize determi-
must have engaged ligand in order to activate the T cell. nants present on both a and b chains in the putative
Results are discussed with respect to the following: the peptide–MHC binding site of the TCR (Soo Hoo et al.,
topologies and affinities of SE binding by the TCR; the 1992; Schodin and Kranz, 1993). It has also been shown
relationship between the number of TCRs required for previously that 1B2 can inhibit SEB-mediated recogni-
activation and ligand density; and the relationship be- tion of Daudi cells by 2C (Soo Hoo and Kranz, 1993).
tween the number of TCRs required for activation and However, it was not known whether SEC1- and SEC3-
TCR affinity. mediated recognition of Daudi by 2C would also be
Finally, these relationships were used to examine sev- inhibited with 1B2. To determine whether this was the
eral QL9 variants at position 5 (Phe) of the peptide. The case, various concentrations of 1B2 Fab fragments were
analyses showed that the affinity of the 2C TCRs for incubated with 2C cells and 51Cr-labeled Daudi cells,
these variantsspanned a range of three orders of magni- together with each of the SEs. 1B2 completely inhibited
tude (e.g., Ka 5 2.2 3 104 M21 and 2.6 3 107 M21 for QL9- the 2C-mediated lysis of all three SE–Daudi complexes
D5/Ld and QL9-H5/Ld, respectively). Thus, this position (Figure 2). Thus, 1B2 could be used with all of the pep-
ispredicted to have a significant effect on the interaction tide–MHC and SE–MHC ligands to examine the number
of QL9–Ld with the 2C TCR. of TCRs required for recognition.
Results Effect of Ligand Density on the Number
of TCR Required for Recognition
Peptide–MHC and SE Recognition by CTL 2C To examine the number of TCRs required for recognition
The CTL 2C recognizes an allogeneic complex of the of the various peptide–MHC or SE–MHC ligands, mono-
peptides p2Ca (LSPFPFDL) or QL9 (QLSPFPFDL) bound valent 1B2 Fab fragments that bind to the TCR, but do
to Ld (Udaka et al., 1992; Sykulev et al., 1994b). These not activate the CTL, were used to control the number
peptides are derived from the ubiquitous enzyme of available TCR on the surface of the CTL clone 2C.
a-ketoglutarate dehydrogenase (Udaka et al., 1993). The number of unbound TCR on the cell at a particular
p2Ca binds to Ld with an affinity of 7 3 105 M21 (Kagey- 1B2 Fab concentration can be calculated from the affin-
ama et al., 1995) and the p2Ca–Ld complex binds to the ity of 1B2 Fab fragments for the TCR (Ka 5 2 3 108 M21;
2C TCR with an affinity of 2 3 106 M21 (Sykulev et al., Sykulev et al., 1994a) and the number of total TCRs per
1994a). QL9 binds to Ld with an affinity of 1.5 3 108 M21 2C cell (100,000/cell; Sykulev et al., 1994b). Thus, by
and the QL9–Ld complex binds the TCR with an affinity determining the concentration of 1B2 required to
of 2 3 107 M21 (Sykulev et al., 1994b). Single-site variants achieve 50% lysis of a particular target cell (IC50), it
of QL9 and p2Ca have been examined for their effects is possible to determine the number of unbound TCR
on Ld binding and TCR binding (summarized in Table ([TCR]free) required under these conditions, using the fol-
1) (Sykulev et al., 1994a; Al-Ramadi et al., 1995; C. J. lowing equation (Karush, 1970):
Schlueter et al., submitted). In this study, QL9, p2Ca,
and several variant peptides were used in a cytotoxicity Ka 3 IC50(1) [TCR]free 5 (1 2 ) 3 100,000assay with CTL 2C to determine the ability of 2C to 1 1 Ka 3 IC50
recognize target cells that have various ligand densities
Furthermore, the number of peptide–MHC complexeson the surface. The target cells were T2–Ld and T2–Kb,
on the surface of T2–Ld or T2–Kb or SE–MHC on Daudimutant lymphoblastoid cell lines transfected with Ld and
can be varied by adding different concentrations of pep-Kb, respectively. At nonsaturating peptide concentra-
tide or SE. The average number of peptide–MHC ortions, incubation of these target cells with exogenously
superantigen–MHC molecules on the surface of the tar-added peptide increases the number of MHC on the
get cell [pep–MHC] at a particular concentration of pep-surface of the cell proportional to the affinity of the
tide (or SE) was calculated using the following equationpeptide for the MHC (Lie et al., 1990; C. J. Schlueter et
al., submitted). (Karush, 1970; Kageyama et al., 1995):
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Figure 1. SE-Mediated Lysis of Target Cells by CTL Clone 2C
Figure 2. Inhibition of SE-Mediated Lysis by 1B2 Fab FragmentsSEB, SEC1, and SEC3 were tested at various concentrations in a
A cytotoxicity assay was used to determine whether 1B2 Fab frag-cytotoxicity assay with CTL 2C. We incubated 2 3 104 51Cr-labeled
ments could inhibit the 2C-mediated recognition of SEB, SEC1, andDaudi cells with increasing concentrations of SEB, SEC1, and SEC3
SEC3 bound to Daudi cells. We incubated 2 3 104 51Cr-labeled Daudifor 1 hr at 378C. We added 105 2C cells and the assay was incubated
cells with 1 mg/ml of SE for 1 hr at 378C. The indicated concentrationsat 378C for 4 hr. Supernatants were removed and monitored for 51Cr.
of 1B2 Fab fragments and 105 2C cells were added and the incuba-Data from a representative set of experiments are shown. The SEs
tion continued at 378C for 4 hr. Supernatants were removed andachieved maximal 2C-mediated 51Cr release at 10 mg/ml (i.e., in-
monitored for 51Cr. Specific 51Cr release was calculated as describedcreasing the SE concentration above 10 mg/ml did not results in an
in Experimental Procedures.increase in lysis; data not shown).
(Ka 3 [pep]total)(2) [pep–MHC] 5 3 [MHC]total Similarly, SEB, SEC1, and SEC3 were assayed at dif-1 1 Ka 3 [pep]total
ferent concentrations in the presence of various concen-
where [MHC]total is the total number of MHC on cell sur- trations of 1B2 Fab fragments. Daudi cells were incu-
face, Ka is the association constant for peptide–MHC or bated with 10 ng/ml to 100 mg/ml of SEB, SEC1, and
SE–MHC binding, and [pep]total is the concentration of SEC3, and the 2C-mediated lysis was measured in the
exogenously added peptide or superantigen at the be- presence of 1 ng/ml to 120 mg/ml of 1B2 Fab fragments.
ginning of the assay. Using these parameters (Table 1), At the highest concentration of SE, z80% of the MHC
the ligand densities were determined for various pep- are bound. As an example, inhibition curves generated
tides and SEs (Table 2). Total ligand densities are subject for SEB–Daudi are shown in Figure 3 and the number
to some variation due to peptide–MHC or SE–MHC sta- of TCR required at each SE–MHC density is shown in
bility and turnover during a 4 hr cytotoxicity assay at Table 2.
378C. These effects will be less significant at higher From these data, it was possible to compare the num-
saturating concentrations of peptides or SEs. ber of free TCR required at different densities for each
A series of 1B2 inhibition curves was generated for of the ligands (Figure 4; data not shown). Several points
the peptide–MHC ligands shown in Table 2. Peptides can be made from such a presentation of the data. First,
p2Ca, QL9, and QL9–M5, were incubated with T2–Ld at at the lowest ligand densities that are recognized by
concentrations from 10211 M to 3 3 1025 M. At the highest 2C, each requires nearly the entire complement of cell
concentration of peptide, >95% of the available MHC surface TCR (i.e., > 50,000 unbound TCRs/cell). This
molecules are bound by the added peptide (saturating finding is perhaps not unexpected, as this ligand density
peptide concentrations). p2Ca–A8 and QL9–D5 were in- is by definition the threshold required for activity. How-
cubated with T2–Ld and p2Ca was incubated with T2–Kb ever, at higher ligand densities, the number of unbound
at concentrations of 1028 M to 1024 M. Each of these TCR required varied dramatically, by almost two orders
peptides reached saturating concentrations except of magnitude, among the different ligands. Thus, several
p2Ca–A8, for which only 40% of MHC molecules are of the ligands at high density required only 500–1,000
calculated to be bound at 1024 M p2Ca–A8. For each free TCRs for recognition.
peptide concentration tested, lysis of the target cells by
2C was measured in the presence of 1 ng/ml to 120
mg/ml of 1B2 Fab fragments. As an example, inhibition Number of TCRs Required to Recognize Ligands
with Different Affinities for the TCRcurves generated for p2Ca incubated with T2-Ld are
shown in Figure 3. Table 2 shows the number of TCRs It seemed reasonable to predict that the differences
among ligands in the number of TCRs required at highrequired at each ligand density for each of the peptides
listed above. Titrations for each of these peptides was ligand densities could be due to the affinity of the TCR
for the particular ligand. Because many of the 2C ligandsperformed at least twice with very similar results.
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Table 1. Summary of Binding Properties of Peptides and Enterotoxins and the Number of Free TCRs Required at Saturating
Peptide–MHC or SE–MHC Densities
Peptide Sequence MHC Ka of peptide for MHC Ka of ligand for TCR Number of free TCR at saturationj
M21 M21
p2Ca LSPFPFDL Ld 7 3 105
a
2 3 106
b
1000k
p2Ca–A8 LSPFPFDA Ld 7 3 103
b
2 3 106
b
10000i
QL9 QLSPFPFDL Ld 1.5 3 108
c
2 3 107
c
1000
QL9–M5 QLSPMPFDL Ld 1.0 3 109
d
z1 3 106
d
5000
QL9–R5 QLSPRPFDL Ld 1.4 3 109
d
— 2000
QL9–D5 QLSPDPFDL Ld 4.8 3 106
d
— 36000
QL9–H5 QLSPHPFDL Ld 1.2 3 108
d
— ,500
QL9–Y5 QLSPYPFDL Ld 4.1 3 108
d
z1 3 107
d
,500
QL9–K5 QLSPKPFDL Ld 2.0 3 108
d
— 12000
p2Ca LSPFPFDL Kb 4 3 104
b
3 3 103
b
65000
QL9 QLSPFPFDL Kb — — 51000
Enterotoxin
SEB Class II 1 3 106
e, f, g
7 3 103
h
65000
SEC1 Class II 1.3 3 106g 9 3 104h 32000
SEC3 Class II — 2 3 105
h
10000
a Kageyama et al., 1995.
b Sykulev et al., 1994a.
c Sykulev et al., 1994b.
d C. J. Schleuter et al., submitted.
e Seth et al., 1994.
f Scholl et al., 1989.
g Mollick et al., 1991.
h Malchiodi et al., 1995. Malchiodi et al. report two affinity values for SEC1 and SEC3 binding to the TCR, one measured by sedimentation
equilibrium and one measured using BIAcore data. For this study, the average of the two values was used.
i 40% saturation.
j Concentration of peptide such that . 95% of class I MHC or 80% of class II MHC is complexed. Percent of MHC bound was determined
from the Ka of the peptide for the MHC.
k Free TCRs/cell was calculated from the concentration of 1B2 Fab fragments that yielded 50% inhibition using a Ka for 1B2 of 2 3 108 M21
and 100,000 TCRs per cell. Each assay was done in triplicate and each peptide was titrated at least twice. The reported values are the average
of the titrations.
in this study have been characterized for their TCR affini- incubated with T2–Ld, and 1024 M of QL9 was incubated
with T2–Kb, and the 2C-mediated lysis was inhibited withties, it was possible to plot TCR affinity versus the num-
ber of TCRs required at different ligand densities (1,000, 1 ng/ml to 120 mg/ml of 1B2. Table 1 shows the number
of TCRs required at saturating peptide concentrations10,000, and saturating peptide–MHC or SE–MHC per
cell; Figure 5A). As is apparent from this analysis, there for all of the peptides used in this study. The number
of TCRs required for each peptide listed above wasis a clear inverse correlation between the number of
TCRs required and the Ka of the TCR–ligand interaction. plotted on the correlation curve generated at saturating
peptide concentrations (Figure 5B). The Ka values ofAt the lowest ligand densities that lead to T cell activity
(<1,000 ligands/cell) the affinity of the TCR for ligand each peptide–MHC complex for the TCR were calcu-
lated by linear regression of this curve (Figure 5B). Thedoes not have much of an effect on the number of TCR
required (i.e., all peptides or SE required > 50,000 total analyses showed that the affinity of the 2C TCR for these
variants spanned three orders of magnitude (e.g., Ka 5TCR). At the highest ligand densities, the affinity of the
ligand for the TCR accounts for the large differences 2.2 3 104 M21 and 2.6 3 107 M21 for QL9-D5/Ld and QL9-
H5/Ld, respectively).between the number of TCR required. Extrapolation to
the total number of TCR on a cell (i.e., 100,000 on the
y-axis), indicates that a Ka of z5 3 103 M21 would be Prediction of Ligand Densities from Number
of TCRs Required for Activitythe lowest possible affinity that would stimulate CTL 2C
at the highest ligand concentrations. From the relationship described above for ligand density
on a target cell and the number of TCRs required for
CTL activity, it should be possible to determine ligandPrediction of TCR Binding Affinities from
Number of TCRs Required for Activity densities for an unknown. For example, the cellular tar-
get for CTL 2C is an Ld alloantigen-bearing cell suchUsing the correlation curves generated above, it may
bepossible topredict the Ka of a particular peptide–MHC as the DBA/2-derived mastocytoma P815 (Kranz et al.,
1984a). Inhibition of P815 target cell lysis with 1B2 Fabcomplex by knowing the number of TCRs required at a
certain ligand density. Therefore, the number of TCRs fragments showed that 38,000 total TCRs were required
(data not shown). Interpolation of this value using therequired at saturating peptide concentrations for several
peptides for which there was no binding affinity data was p2Ca activity curve (see Figure 4) predicts that there are
z800 p2Ca–Ld ligands per P815 cell. This estimate isdetermined using the inhibition assay.Peptides QL9-R5,
QL9-H5, QL9-K5 (3 3 1025 M) and QL9-D5 (1024 M) were slightly higher than the value of z400 p2Ca peptides
T Cell Receptor Activation Requirements
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Table 2. Number of Free TCRs Required for Recognition of Peptide–MHC and SE–Class II Compared with Ligand Density on Target
Cell
Ligand Concentration (M) Percent bound MHCa Number ligands/cellb Number free TCR/cellc
QL9–Ld 3 3 1025 99.9 29,900 1,000
1 3 1026 99.3 29,800 1,600
1 3 1027 94 28,100 2,000
1 3 1028 60 18,000 9,000
1 3 1029 13 1,900 25,000
1 3 10210 1.5 400 48,000
p2Ca–Ld 3 3 1025 95 28,600 1,000
1 3 1026 41 12,400 6,000
1 3 1027 6.5 2,000 27,000
1 3 1028 0.7 200 42,000
1 3 1029 0.07 21 88,000
QL9–M5/Ld 3 3 1025 99.9 29,900 5,000
1 3 1027 99 29,700 2,700
1 3 1028 91 27,300 4,000
1 3 1029 50 15,000 8,000
1 3 10210 10 3,000 24,000
1 3 10211 1.0 300 63,000
QL9–D5/Ld 1 3 1024 99.7 29,900 36,000
1 3 1025 98 29,400 40,000
1 3 1026 83 24,800 56,000
1 3 1027 32 9,700 67,000
1 3 1028 4.6 1,400 67,000
p2C–A8/Ld 1 3 1024 41 12,400 10,000
1 3 1025 6.5 2,000 49,000
1 3 1026 0.7 200 72,000
1 3 1027 0.07 21 93,000
1 3 1028 0.007 2 91,000
p2Ca–Kb 1 3 1024 80 16,000 65,000
1 3 1025 29 5,800 67,000
1 3 1026 3.8 760 81,000
SEB/HLA-DR 3.5 3 1026 78 780,000 65,000
3.5 3 1027 26 260,000 66,000
3.5 3 1028 3.4 34,000 78,000
3.5 3 1029 0.35 3,500 81,000
3.5 3 10210 0.035 350 82,000
SEC1/HLA-DR 3.6 3 1026 82 820,000 32,000
3.6 3 1027 32 320,000 39,000
3.6 3 1028 4.5 45,000 41,000
3.6 3 1029 0.47 4,500 53,000
3.6 3 10210 0.047 450 74,000
a Percent MHC bound was determined from the Ka of the peptide or enterotoxin for the MHC and the concentration of peptide or enterotoxin
added to the assay.
b Determined from published values of 30,000 Ld on surface of T2–Ld and 20,000 Kb on surface of T2–Kb (Kageyama et al., 1995), and total
number of class II per Daudi of 1,000,000 (D. M. K., unpublished data).
c Free TCRs/cell was calculated from the concentration of 1B2 Fab fragments that yielded 50% inhibition using a Ka for 1B2 of 2 3 108 M21
and 100,000 TCRs per cell. Each assay was done in triplicate, and each peptide titration was performed at least twice. The average of the
values is reported.
perBALB/c spleen cell isolated using biochemical purifi- very strong inverse correlation between the affinity of
the TCR for its ligand and the number of TCRs requiredcation methods (Udaka et al., 1992). However, peptides
other than p2Ca (including the p2Ca precursor, p2Cb) for T cell activity allows a simple assay to be used to
begin to determine the influence of TCR affinity on Tthat are recognized in complex with Ld by the 2C TCR
have been isolated from BALB/c cells and P815 cells cell activity. The CTL clone 2C was used in this analysis
(Udaka et al., 1992, 1993). These peptides no doubt because there are a variety of different ligands (peptide–
contribute to the total ligand density that has been mea- MHC and superantigen–MHC) that are recognized by
sured in the assay described here. 2C (Udaka et al., 1992; Sykulev et al., 1994b; Marrack
and Kappler, 1990) and a clonotypic antibody, 1B2, that
binds to the TCR on 2C (Kranz et al., 1984b). Many ofDiscussion
the ligands that are recognized by 2C have been well
characterized (Table 1), and the nominal peptide–MHCThe findings described in this report address the rela-
complex, QL9–Ld, has the highest known affinity for ationships among TCR affinity, TCR density, ligand den-
sity, and T cell activity. The observation that there is a TCR (Sykulev et al., 1994b). Thus, the range of binding
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Figure 3. 1B2 Inhibition of 2C-Mediated Ly-
sis of Target Cells that Express Different Den-
sities of Cell Surface Ligand
Various concentrations of p2Ca or SEB that
yielded a range from high to low ligand densi-
ties were used in a cytotoxicity assay with
CTL 2C. At each peptide or SEB concentra-
tion, the indicated concentration of 1B2 Fab
fragments was included to generate a set of
inhibition curves. The 1B2 concentration at
50% inhibition was determined from the
curves, and the number of free TCR was cal-
culated from that value as described in Ex-
perimental Procedures. Eachassay point was
done in triplicate and the titrations were per-
formed at least twice. Data from one repre-
sentative set of experiments for p2Ca–T2-Ld and SEB–Daudi are shown. In the first panel, 2 3 104 51Cr-labeled T2–Ld cells were incubated
with 3 3 1025 M (closed circles), 1026 M (open circles), 1027 M (closed squares), 1028 M (open squares), or 1029 M (closed triangles) p2Ca for
1 hr at 378C. At each peptide concentration, the indicated concentrations of 1B2 and 105 2C cells were added and the assay was incubated
for 4 hr. Supernatants were removed and monitored for 51Cr. For the experiments shown, maximal 2C-mediated release was 39% at the
highest peptide concentration and 16% at the lowest peptide concentration. In the second panel, 2 3 104 51Cr-labeled Daudi cells were
incubated with 100 (closed circles), 10 (open circles), 1 (closed squares), 0.1 (open squares), or 0.01 mg/ml (closed triangles) SEB for 1 hr at
378C. Various concentrations of 1B2 and 105 2C cells were added and the assay was incubated for 4 hr at 378C. Supernatants were removed
and monitored for 51Cr release. For the experiments shown, maximal 2C-mediated 51Cr release was 39% at the highest SEB concentration
and 10% at the lowest SEB concentration.
affinities of the 2C TCR for its ligands ranged over three among TCR affinity, ligand density, and activity. Addi-
tionally, the variety of ligands used in this study haveorders of magnitude.
The strategy of using anti-TCR antibodies to study some bearing on issues such as the TCR-binding site
topology of SEs, T cell activation thresholds, and thevarious aspects of T cell recognition is not new (Kaye
and Janeway, 1984; Rojo and Janeway, 1988), but the quantitation of low affinity TCR–ligand interactions.
ability to quantitate the number of TCRs required for
activity allowed a unique analysis of the relationships
Topology of Superantigen Binding Site(s)
It has been suggested recently that SEC3 contacts the
CDR1, CDR2, and HV4 regions on the TCR b chain (Mal-
chiodi et al., 1995). The clonotypic antibody 1B2 has
been shown by a number of approaches to require both
the a and b chains of the 2C TCR and thus its epitope
is presumed to include CDR contact residues contrib-
uted by both chains (Sha et al., 1988; Lipes et al., 1993;
Schodin and Kranz, 1993). The observation that 1B2
Fab fragments inhibited all three SE ligand interactions
suggests that SEB, SEC1, and SEC3 binding sites are in
reasonably close proximity to each other. Furthermore,
1B2 Fab fragments inhibit both peptide–MHC ligand and
SE–MHC ligand binding to the TCR, supporting the idea
that the SE–MHC binding site is in close proximity to
the peptide–MHC binding site (Woodland et al., 1993;
Deckhut et al., 1994; Jardetsky et al. 1994). In contrast,
the anti-Vb8 antibody KJ16 can compete with the SEB
binding site on the 2C TCR but not with the peptide–
MHC binding site on the 2C TCR (Cho et al., 1995).
Malchiodi et al. (1995) have also recently shown that
SEB, SEC1, and SEC3 bind directly to soluble TCR with
Figure 4. Relationship of Number of Ligands per Target Cell and
Ka values of z7 3 103, 9 3 104, and 2 3 105 M21, respec-the Number of TCRs Required for Activity
tively. In the CTL assay with Daudi target cells, the com-The number of 2C TCR required for recognition of various ligands
plex of SE and HLA-DR is presumably the ligand exam-was plotted as a function of the number of ligands on the target
ined using 1B2 Fab fragments. As discussed below,cell. The number of p2Ca–Ld, QL9–Ld, QL9-D5–Ld, SEB–class II, or
SEC1–class II complexes was calculated from the Ka of the peptide the affinity of the soluble SE–TCR interaction directly
or SE for MHC and the concentration of peptide or SE added in the correlated with the number of TCRs required for T cell
assay. The number of TCR required for recognition was determined activity. One interpretation of these results is that the
from the concentration of 1B2 Fab fragments required at 50% inhibi-
affinity of SE/HLA-DR for the TCR will not differ appreci-tion of cytolysis, using a Ka of 2 3 108 M21 and 100,000 TCRs per
ably from the affinity of the SE alone for the TCR (asT cell, as described in Experimental Procedures. Data are taken
from Table 2. measured by Malchiodi et al., 1995, and used in the
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Figure 5. Correlation Between the Binding
Affinity of the TCRfor Its Ligand and the Num-
ber of TCRs Required for T Cell Activity
(A) Ka values from previous reports are sum-
marized in Table 1. The number of TCR at
>25,000 ligands (open circles) was deter-
mined at saturating ligand concentrations for
each of the peptides or superantigens that
have a published binding affinity for the 2C
TCR. The number of TCRs at 1,000 (open tri-
angles) and 10,000 (closed squares) ligands
were calculated by regression analysis from
the data summarized in Table 2.
(B) Ka values for the TCR interaction with the
indicated peptide–class I complexes were
predicted from the number of TCRs required
for activity. The curve determined from
known Ka values for several TCR–ligand inter-
actions was plotted versus number of TCRs
at saturating ligand concentrations (open cir-
cles) to generate a standard curve. The inhi-
bition analysis was used to determine the
number of TCRs required at 3 3 1025 M QL9-
H5, QL9-R5, QL9-H5 and 1024 M QL9-D5 with
T2–Ld and 1024 M QL9 with T2–Kb. These val-
ues were plotted on the standard curve
(closed circles) to calculate by linear regres-
sion a predicted Ka value for TCR binding to
each of the peptide–class I complexes.
analysis in Figure 5). If this is the case, then the contribu- nearly all of the cell surface TCR, regardless of the affin-
ity of the TCR for the ligand. Under these conditions,tion of class II–TCR interactions to the binding energy
for these superantigens would be minimal. the Ka of the TCR determines the lowest level of ligand
that is required for T cell activity (Sykulev et al., 1994b).In contrast with results of the present study, Malchiodi
et al. (1995) showed that their Th cell line is stimulated We show here that at high ligand densities (i.e., > 10,000
ligands/cell), the affinity of the TCR for the ligand deter-preferentially with SEB–class II compared with SEC1–
and SEC3–class II. Two differences in the experiments mines how many TCRs per T cell are needed for activity.
For high affinity ligands, the T cell required z500–1,000with CTL 2C and the Th cell line could possibly account
for this discrepancy. First, different class II products free TCRs to be activated. In contrast, the lowest affinity
ligands required virtually all of the available TCRs, al-were used in the two studies and it is known that the
same enterotoxin can bind with different affinities to though we do not mean to imply that all of these TCRs
are engaged with ligand at the same time. The numberdifferent class II products (Mollick et al., 1991). Alterna-
tively, Th assays are conducted over 3 days, while the of engaged TCRs is expected to be lower than the total
number of TCRs (Brower et al., 1994), but it is possibleCTL assay described here is only 4 hr in length. Accord-
ingly, the temperature stabilities of SEs may differ that each ligand may serially contact as many as 200
different TCRs (Valitutti et al., 1995). This possibility isand SEB may have a longer lifetime than SEC1 or SEC3
at 378C. interesting in view of the recent evidence that a single
QL9–Ld complex appears to be sufficient to trigger 2C,
at the normal level of 100,000 TCR/CTL (Sykulev et al.,Relationship Between the Number of TCRs Required
for Activation and Ligand Density 1996). In the present study, when there were z30,000
QL9–Ld complexes per target cell, z1,000 total TCRsFor all of the ligands tested, the lowest ligand densities
recognized by 2C (i.e., < 1,000 ligands/cell) required were required for T cell activity (i.e., more than just a
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few TCRs, as might have been predicted from the results affinities measured at 208C–258C using the BIAcore sys-
tem. Using a single-chain TCR from 2C, we also identi-of Sykulev et al., 1996). These results are consistent
with the notion that a single ligand may need to trigger fied peptide–Ld ligands (e.g., QL9-H5) that did not de-
tectably to bind to the TCR (at 48C), yet had highmany TCRs, either by association of multiple TCR com-
plexes in the membrane (Fields et al., 1995) or by a biological activity. Interestingly, based on the relation-
ship depicted in Figure 5, QL9-H5 was predicted to haveconformational change (Yoon et al., 1994).
Another aspect of this approach involves the use of a relatively high affinity for the 2C TCR. In considering
a possible explanation, it became clear that all of theinhibition curves to determine the number of ligands on
a target cell. It is routine to use synthetic peptides to published TCR binding studies have been performed at
lower temperatures (48C–258C), whereas the measure-generate activity curves for T cells in which the peptide
ligand has been identified. Using an anti-TCR antibody, ments of CTL activity and the inhibition curves described
here are performed at 378C. Temperature effects onit should now be possible to determine the number of
free TCRs required at different ligand densities. Inhibi- peptide–MHC or TCR structure and affinity may explain
such seemingly anomalous cases. We have recent evi-tion analysis of target cells that have endogenously pro-
cessed antigens, such as viral or tumor peptides or dence that temperature can account for at least theQL9-
H5 discrepancy (i.e., binding of the TCR was detected atendogenous superantigens, can be used to estimate
the number of cell surface ligands. This measurement 378C but not at 48C; C. J. Schlueter et al., submitted).
Alternatively, the true correlation depicted in Figure 5has been extremely difficult to make using biochemical
approaches. may be dissociation rates rather than affinity constants,
as has been suggested by Davis and colleagues (Matsui
et al., 1994).Relationship Between the Number of TCRs
Required for Activation and TCR Affinity The studies described here refer to a CTL that has
already been activated against the specific alloantigen.The 2C TCR interaction with QL9–Ld has the highest
affinity yetdescribed between a TCR and ligand (Sykulev It has been shown that the ligand density required ini-
tially to activate such T cells may be an order of magni-et al., 1994b). Several other ligands have been described
for the 2C TCR that span a range of affinities of three tude higher than this density (Yagi and Janeway, 1990).
Similarly, naive T cells and activated Th1 and Th2 cellsorders of magnitude (summarized in Table 1). It has been
shown previously that CTL activity is not only dependent may have their own thresholds of signaling for different
effector functions or for the induction of anergy. Theon TCR–ligand affinity, but that it follows the law of
mass action (Sykulev et al., 1995). That is, higher affinity relationship described here between TCR affinity and
the number of TCRs required may provide a strategyinteractions require lower ligand concentrations for acti-
vation. The experimental results presented here also for examining these questions. For example, 2C TCR
transgenic mice can be used together with the 1B2 anti-follow the law of mass action. That is, higher affinity
interactions require lower TCR concentrations for acti- body and appropriate populations of naive T cells. Alter-
natively, anti-Vb antibodies can be used with superanti-vation. This relationship allows certain predictions to be
made about the minimal affinities necessary for T cell gens as ligands to evaluate other systems.
activation and about the minimal numbers of ligands
Experimental Proceduresnecessary at a given TCR affinity. As indicated above,
extrapolation of the curve in Figure 5 to the total TCR
Cell Linesdensity on a mature T cell yields an affinity (Ka) threshold CTL clone 2C, a BALB.B alloreactive CTL (Kranz et al., 1984a) spe-
of 5 3 103 M21. This value is nearly identical to that cific for the MHC molecule Ld (Udaka et al., 1992), was maintained
predicted on more theoretical grounds (Brower et al., in RPMI 1640 medium supplemented with 10% fetal bovine serum,
1994). Conversely, if one extrapolates to the minimum 5 mM HEPES, 1.3 mM L-glutamine, 50 mM 2-mercaptoethanol, peni-
cillin, and streptomycin. 2C was stimulated every week with mitomy-number of TCRs required (1–10 per T cell for purposes
cin C-treated BALB/c spleen cells and10% supernatant from conca-of this example) then the Ka would need to be in the
navalin A-stimulated rat spleen cells. T2–Ld and T2–Kb, humanrange of 109 M21. This value is very similar to the notion
mutant lymphoblastoid cell lines transfected with the a chain genes
of a maximum affinity “ceiling,” above which no in- of Ld and Kb, respectively (Alexander et al., 1989), were maintained
creases in biological activity could be achieved (Sykulev in RPMI medium plus 0.5 mg/ml Geneticin. Daudi, a human lym-
et al., 1995). phoma that expresses class II was maintained in supplemented
RPMI medium.Low affinity interactions are notoriously difficult to
measure directly because of the quantities of soluble
Preparation of 1B2 Fab FragmentsTCR, ligand, or both required for binding studies. It is
1B2 is a clonotypic antibody specific for the TCR on 2C (Kranz etworth noting that the anti-TCR inhibition assay is able
al., 1984b). Intact 1B2 was purified from ascites fluid of mice by
to evaluate the lowest affinity interactions (e.g., with precipitation with 50% ammonium sulfate. Fab fragments were pro-
p2Ca–Kb and SEB–class II) as easily as high affinity inter- duced by digestion of intact antibody with papain (Sigma) and puri-
actions because low affinity ligands require very small fied by chromatography through a Superdex 200 column in phos-
phate-buffered saline (pH 7.3). SDS–PAGE confirmed that thequantities of the Fab fragments to inhibit activity. Thus,
purified Fabs were >95% free of intact immunogloblin (data notthe strategy described here provides an alternative ap-
shown).proach to this problem.
Al-Ramadi et al. (1995) have used anti-CD8 antibodies Peptides/Superantigens
to arrive at a similar conclusion. That is, the concentra- Peptides were synthesized by the Genetic Engineering facility at
tion of anti-CD8 antibodies required for inhibition corre- the University of Illinois and purified by reverse phase high pressure
liquid chromatography on a C18 column. Peptides were analyzed forlated more with SD50 values than actual TCR binding
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purity by mass spectrometry and for concentration by quantitative on the surface of T2–Ld; 20,000 Kb on the surface of T2–Kb (Kageyama
et al., 1995); and 1,000,000 class II–MHC on the surface of Daudi.amino acid analysis. The peptides were the following: QL9
(QLSPFPFDL), QL9-M5 (QLSPMPFDL), QL9-R5 (QLSPRPFDL), QL9- The latter value was determined by saturation binding to Daudi cells
with 125I-labeled anti-DR, anti-DP, anti-DQ antibody (Pharmingen)D5 (QLSPDPFDL), QL9-K5 (QLSPKPFDL), QL9-H5 (QLSPHPFDL),
QL9-Y5 (QLSPYPFDL), and p2Ca (LSPFPFDL). Peptide p2Ca–A8 (D. M. K., unpublished data). The affinities of the peptide or superan-
tigen for the MHC and the affinitiesof the peptide–MHC orsuperanti-(LSPFPFDA) was provided by the H. Eisen laboratory. SEB, SEC1,
and SEC3 were purchased from Toxin Technology, Incorporated gen for the TCR used in this study are summarized in Table 1.
(Sarasota, Florida).
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